Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, P.O Box 330127, Zarqa 13133, Jordan.
Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Int J Clin Pract. 2022 Jun 27;2022:8080308. doi: 10.1155/2022/8080308. eCollection 2022.
Pharmacists in all clinical settings are recognized drug experts and integral educators of biosimilar medicines. Therefore, the objective of this study was to assess pharmacists' knowledge, predictors of knowledge, and views toward biosimilar medicines in Jordan.
A cross-sectional study was conducted in Jordan during October-December 2020. An Internet-based self-administrated questionnaire on knowledge and views was distributed using social media groups to the pharmacists among different areas in Jordan. A descriptive and univariate analysis was performed. Binary logistic regression was conducted to determine the predictors of knowledge including all variables with < 0.20 on univariate analysis.
A total 536 responses were received, 502 of which were completed (93.7% response rate). A total of 52.6% of the pharmacists were knowledgeable about biosimilar medicines and the mean of knowledge level was 6.47 ± 1.62 (range 2-10). Multivariate analysis identified that respondents who had heard about biosimilars before (OR = 1.942, 95% CI = 1.231-3.063, < 0.05) was more likely to be knowledgeable. Respondents who had not taken the course or the postgraduating training course about biosimilars that were less likely to be knowledgeable (OR = 0.548, 95% CI = 0.357-0.839, < 0.05). A positive response was noted in pharmacist's view regarding the implementation of biosimilar medicines in healthcare setting, biosimilar medicine prescription related to decreased costs, self-study about biosimilar medicine, and incorporating biosimilar education program at the pharmacy school curriculum universities level.
Pharmacists' views and knowledge vary regarding the particularities and key issues on biosimilar medicines in Jordan. Incorporating biosimilar course in pharmacy school curriculum could improve their acceptance for future pharmacy jobs.
在所有临床环境中，药剂师都被公认为药物专家和生物类似药的重要教育者。因此，本研究的目的是评估约旦药剂师对生物类似药的知识、知识预测因素和看法。
本研究于 2020 年 10 月至 12 月在约旦进行了一项横断面研究。通过社交媒体群组向约旦不同地区的药剂师分发了一份关于知识和观点的基于互联网的自我管理问卷。进行了描述性和单变量分析。进行了二元逻辑回归分析，以确定知识的预测因素，包括单变量分析中 < 0.20 的所有变量。
共收到 536 份回复，其中 502 份完成（93.7%的回复率）。共有 52.6%的药剂师对生物类似药有一定的了解，知识水平的平均得分为 6.47±1.62（范围 2-10）。多变量分析表明，以前听说过生物类似药的受访者（OR=1.942，95%CI=1.231-3.063， < 0.05）更有可能了解生物类似药。没有参加过生物类似物课程或研究生培训课程的受访者不太可能了解生物类似物（OR=0.548，95%CI=0.357-0.839， < 0.05）。药剂师对在医疗保健环境中实施生物类似药、生物类似药处方与降低成本、自我学习生物类似药以及在药学院校课程中纳入生物类似物教育计划等方面的看法持积极态度。
约旦药剂师对生物类似药的特殊性和关键问题的看法和知识存在差异。在药学院校课程中纳入生物类似物课程可以提高他们对未来药学工作的接受程度。
